Cargando…
vCJD risk in the Republic of Ireland
BACKGROUND: The Republic of Ireland has the second highest incidence of BSE worldwide. Only a single case of vCJD has been identified to date. METHODS: We estimate the total future number of clinical cases of vCJD using an established mathematical model, and based on infectivity of bovine tissue cal...
Autores principales: | , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC305349/ https://www.ncbi.nlm.nih.gov/pubmed/14641933 http://dx.doi.org/10.1186/1471-2334-3-28 |
_version_ | 1782121099248533504 |
---|---|
author | Harney, Michael S Ghani, Azra C Donnelly, CA Walsh, Rory McConn Walsh, Michael Howley, Rachel Brett, Francesca Farrell, Michael |
author_facet | Harney, Michael S Ghani, Azra C Donnelly, CA Walsh, Rory McConn Walsh, Michael Howley, Rachel Brett, Francesca Farrell, Michael |
author_sort | Harney, Michael S |
collection | PubMed |
description | BACKGROUND: The Republic of Ireland has the second highest incidence of BSE worldwide. Only a single case of vCJD has been identified to date. METHODS: We estimate the total future number of clinical cases of vCJD using an established mathematical model, and based on infectivity of bovine tissue calculated from UK data and on the relative exposure to BSE contaminated meat. RESULTS: We estimate 1 future clinical case (95% CI 0 – 15) of vCJD in the Republic of Ireland. Irish exposure is from BSE infected indigenous beef products and from imported UK beef products. Additionally, 2.5% of the Irish population was exposed to UK beef through residing in the UK during the 'at-risk' period. The relative proportion of risk attributable to each of these three exposures individually is 2:2:1 respectively. CONCLUSIONS: The low numbers of future vCJD cases estimated in this study is reassuring for the Irish population and for other countries with a similar level of BSE exposure. |
format | Text |
id | pubmed-305349 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2003 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-3053492004-01-01 vCJD risk in the Republic of Ireland Harney, Michael S Ghani, Azra C Donnelly, CA Walsh, Rory McConn Walsh, Michael Howley, Rachel Brett, Francesca Farrell, Michael BMC Infect Dis Research Article BACKGROUND: The Republic of Ireland has the second highest incidence of BSE worldwide. Only a single case of vCJD has been identified to date. METHODS: We estimate the total future number of clinical cases of vCJD using an established mathematical model, and based on infectivity of bovine tissue calculated from UK data and on the relative exposure to BSE contaminated meat. RESULTS: We estimate 1 future clinical case (95% CI 0 – 15) of vCJD in the Republic of Ireland. Irish exposure is from BSE infected indigenous beef products and from imported UK beef products. Additionally, 2.5% of the Irish population was exposed to UK beef through residing in the UK during the 'at-risk' period. The relative proportion of risk attributable to each of these three exposures individually is 2:2:1 respectively. CONCLUSIONS: The low numbers of future vCJD cases estimated in this study is reassuring for the Irish population and for other countries with a similar level of BSE exposure. BioMed Central 2003-11-26 /pmc/articles/PMC305349/ /pubmed/14641933 http://dx.doi.org/10.1186/1471-2334-3-28 Text en Copyright © 2003 Harney et al; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL. |
spellingShingle | Research Article Harney, Michael S Ghani, Azra C Donnelly, CA Walsh, Rory McConn Walsh, Michael Howley, Rachel Brett, Francesca Farrell, Michael vCJD risk in the Republic of Ireland |
title | vCJD risk in the Republic of Ireland |
title_full | vCJD risk in the Republic of Ireland |
title_fullStr | vCJD risk in the Republic of Ireland |
title_full_unstemmed | vCJD risk in the Republic of Ireland |
title_short | vCJD risk in the Republic of Ireland |
title_sort | vcjd risk in the republic of ireland |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC305349/ https://www.ncbi.nlm.nih.gov/pubmed/14641933 http://dx.doi.org/10.1186/1471-2334-3-28 |
work_keys_str_mv | AT harneymichaels vcjdriskintherepublicofireland AT ghaniazrac vcjdriskintherepublicofireland AT donnellyca vcjdriskintherepublicofireland AT walshrorymcconn vcjdriskintherepublicofireland AT walshmichael vcjdriskintherepublicofireland AT howleyrachel vcjdriskintherepublicofireland AT brettfrancesca vcjdriskintherepublicofireland AT farrellmichael vcjdriskintherepublicofireland |